Cardiac Complications of ECT: Myocardial Stunning Syndrome and Takotsubo Cardiomyopathy After ECT

Cristancho, Mario A.; Satterthwaite, Theodore D.; O’Reardon, John P.

doi:10.1097/yct.0b013e3181c185e7

Cited by 5 publications

(6 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…ECT is one stressor known to cause a surge of catecholamines along with a seizure. 11 Catecholamine levels in this syndrome are significantly higher than those found in conditions such as acute myocardial infarction or cardiac failure and up to 34 times higher than normal resting values. It addition, epinephrine at elevated concentrations stimulates a negative inotropic effect on myocyte contraction.…”

mentioning

confidence: 81%

Takotsubo Cardiomyopathy as a Complication of Electroconvulsive Therapy

Sharp

Welch

2011

Ann Pharmacother

View full text Add to dashboard Cite

Takotsubo cardiomyopathy is a serious but transient potential complication of electroconvulsive therapy. Limited evidence indicates that β-adrenergic receptor blocking agents may help prevent its reoccurrence in patients needing further electroconvulsive treatment. Health care providers in psychiatry should be aware of this potential complication of electroconvulsive therapy, especially in postmenopausal women. However, many questions remain regarding this issue.

show abstract

mentioning

confidence: 81%

Takotsubo Cardiomyopathy as a Complication of Electroconvulsive Therapy

Sharp

Welch

2011

Ann Pharmacother

View full text Add to dashboard Cite

show abstract

“…The mean number of treatments received was 9.5 (range [5][6][7][8][9][10][11][12][13][14][15][16][17][18][19][20]. Psychotropic medications were continued.…”

Section: Ect Protocolmentioning

confidence: 99%

“…There are several reports on takotsubo cardiomyopathy after ECT. [8][9][10]32,33 This condition is related to plasma catecholamine levels. 34 One patient in the present study suffered from complications in the form of prolonged tachycardia immediately after ECT.…”

Section: Catecholamine Levels and Cardiovascular Complicationsmentioning

confidence: 99%

See 1 more Smart Citation

Urine catecholamine levels are not influenced by electroconvulsive therapy in depression or schizophrenia over the long term

Ito

Hatta

Usui

et al. 2012

Psychiatry Clin Neurosci

View full text Add to dashboard Cite

Aim: Change in catecholamine seems to be associated with not only effects of electroconvulsive therapy (ECT), but also adverse events associated with ECT. Our aim in this study was to investigate whether or not ECT influences the concentration of catecholamine over the long term. Patients with a major depressive episode or schizophrenia, diagnosed according to DSM-IV criteria, who were newly admitted to Juntendo University Hospital to receive ECT, were recruited.Methods: Urine was collected during the 24 h before the first ECT treatment, during the 24 h after the first ECT treatment, during the 24 h after the final ECT treatment and during the 24 h 1 week after the final ECT treatment. Heart rate, the Hamilton Rating Scale for Depression and the Positive and Negative Syndrome Scale were assessed before and after ECT.Results: Twenty-four patients were included in the final sample, which consisted of 14 patients with major depressive episodes and 10 patients with schizophrenia. Abnormal electrocardiograms were indicated in four patients with depression during the ECT operation but all recovered naturally. There were no significant differences in the levels of dopamine, adrenaline or noradrenaline the day before the first ECT, a day after the first ECT, a day after the final ECT and a week after the final ECT. Conclusion:These results suggest that ECT does not alter urine catecholamine levels after ECT over the long term. Further studies will be required to confirm these findings in a larger sample of patients.

show abstract

“…9,10 For this lady the diagnosis of Takotsubo preceded the adminis tration of ECT; concerns about Takotsubo preexisting are valid as ECT has been documented to lead to the disorder where it did not previously exist. [11][12][13][14][15] It is interest ing to note that in a number of these cases the patient was man aged and ECT subsequently reat tempted. 8,11,15 One review men tioned managing resultant cases by giving beta adrenergic blockers prior to sessions.…”

Section: Takotsubo Cardiomyopathymentioning

confidence: 99%

ECT in a patient with a meningioma and Takotsubo cardiomyopathy

Gani¹,

Parvez²

2016

Prog Neurol Psychiatry

View full text Add to dashboard Cite

There are few studies that look at the use of electroconvulsive therapy (ECT) in elderly patients with a comorbid meningioma or other intracranial tumour, with the dilemma being whether or not to do ECT. This case notes article examines the ECT management of an elderly lady with severe depression, coexisting Takotsubo cardiomyopathy, and an incidental finding of a frontal meningioma. The authors detail the multidisciplinary approach necessary for managing a patient with coincident psychiatric, cardiac and neurological diagnoses and the implications for practice.

show abstract

Cardiac Complications of ECT: Myocardial Stunning Syndrome and Takotsubo Cardiomyopathy After ECT

Cited by 5 publications

References 10 publications

Takotsubo Cardiomyopathy as a Complication of Electroconvulsive Therapy

Takotsubo Cardiomyopathy as a Complication of Electroconvulsive Therapy

Urine catecholamine levels are not influenced by electroconvulsive therapy in depression or schizophrenia over the long term

ECT in a patient with a meningioma and Takotsubo cardiomyopathy

Contact Info

Product

Resources

About